top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
Autore Segelov Eva
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (144 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato 2017 WHO classification
2019 WHO classification
body mass index
cancer care
cancer-driven genes
carcinoid heart disease
carcinoid syndrome
chemotherapy
CommNETs
curative surgery
diabetes mellitus
follow-up
germline mutations
grading
guidelines
liver metastases
long-term functional outcomes
malignant castration-resistant prostatic cells
management
MANEC
medullary thyroid carcinoma
meta-analysis
metastases
metronomic treatment
midgut
MiNENs
mixed adeno-neuroendocrine carcinoma
mixed non-neuroendocrine neuroendocrine neoplasms
modified Delphi
multidisciplinary
mutational mechanism
NETs
neuroendocrine neoplasms
neuroendocrine tumor
neuroendocrine tumors
neuroendocrine tumour
neuroendocrine tumours
NOTCH
outcome
pancreatectomy
pancreatic exocrine insufficiency
pancreatic NET
pancreatic neuroendocrine neoplasms
pancreatic neuroendocrine tumours
parenchyma-sparing surgery
QPIs
quality performance indicators
recurrence
relapse
resection
risk factor
second-line
small bowel NET
small bowel neuroendocrine tumours
small cell lung carcinoma
somatostatin analogues
staging
temozolomide
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557692903321
Segelov Eva  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antitumoral Properties of Natural Products : Volume 2
Antitumoral Properties of Natural Products : Volume 2
Autore Fabiani Roberto
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (300 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato 13-ethylberberine
Akt
AKT
anthraquinones
anti-cancer
anti-cancer activity
anti-cancer agents
anti-tumor activity
anticancer
Antioxidant activities
antioxidants
antioxidation
antiproliferation agents
Antiproliferative
antiproliferative activity
antitumoral activity
antrodin C
apoptosis
AR
Artemisia absinthium
ASE
Aspergillus fumigatus
ATM-Chk2
autophagic flux inhibition
autophagy
bee venom
betulinic acid
Brazilian Cerrado biome
cancer
cancer stem cells
capsazepine
carrageenan
Catalpa speciosa
Celastraceae
cell cycle arrest
cell proliferation
cell signaling
cephalotaxine
cervical cancer
Cheiloclinium cognatum
chemotherapeutic adjuvant
chemotherapy
chiral resolution
CIP2A
CLE-10
CLEFMA
Colocasia esculenta
colorectal cancer cells
copper
Cordyceps sinensis
coronarin D
CrataBL
cryptolepine
Cucurbitacin B
cytotoxic activity
cytotoxicity
Dendrobium officinale
diallyl disulfide
dicentrine
DLD-1 cells
doxorubicin
drug resistance
ECD calculation
EGFR
endoplasmic reticulum stress
entrapment efficiency
Euphorbia tirucalli
FAK/S6K1
flavonoids
folk medicine
food bioactive
FOXO1
fruit
Ganoderma tsugae
gastric cancer
gastric cancer cells
gefitinib-resistant NSCLC
Gene expression
glioblastoma
glioblastoma multiforme
glioma
glucose uptake
glycosyltransferase
grape leaves
human neuroblastoma cells
IL-6/JAK2/STAT3
inflammation
inflammatory diseases
ingenol
invasion
isochromanes
isocryptolepine
JNK
lactoferrin hydrolysate
LC3
lichen
Licochalcone A
lipogenesis
lung adenocarcinoma
lysosomal degradation
lysosomal membrane permeabilization
Magnolia acuminata
manganese
MAPK
MCF-7 cells
MDA-MB-231
melanoma
melittin
mesenchymal stem cells
metabolic stability
metastasis
microenvironment
migration
mitochondrial membrane potential
mitochondrial ROS
mitochondrial-dependent pathway
molecular mechanism
mTOR
multiple myeloma
n/a
naringenin
natural compounds
natural product alkaloids
natural products
natural yellow Monascus pigments
NCI-60 cancer cell line
necrotic
neferine
neocryptolepine
NF-κB
no-toxicity
Nutraceuticals
oncogene
osteosarcoma
p38
patuletin
phenols
phloretin
phytochemicals
PI3K/AKT/mTOR
PI3K/Akt/mTOR pathway
plant lectin
plant-derived foods
plantation mode
Plenckia populnea
porphyran
preclinical tests
pristimerin
pro-apoptotic effects
proanthocyanins
prostate cancer
protease inhibitor
protein kinase C
protein synthesis inhibition
Pulsatilla saponin D
quality control
quercetagetin
quercetin
ROS
RT-R breast cancer cells
Salacia crassifolia
Salacia elliptica
SB365
seaweed
secondary metabolites
semi-synthetic derivative
SREBP-1
stable nanocapsules
stemness potential
structure activity relationships
structure elucidation
tarin
Taxus cuspidata
temozolomide
TNF-α
TP
traditional preparation
transcriptional regulation
triterpenoids
TRPV1
tumidulin
ursolic acid
vegetable
water-soluble
zerumbone
Zeylenone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Antitumoral Properties of Natural Products
Record Nr. UNINA-9910557531303321
Fabiani Roberto  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antitumoral Properties of Natural Products
Antitumoral Properties of Natural Products
Autore Fabiani Roberto
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (344 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato 13-ethylberberine
Akt
AKT
anthraquinones
anti-cancer
anti-cancer activity
anti-cancer agents
anti-tumor activity
anticancer
Antioxidant activities
antioxidants
antioxidation
antiproliferation agents
Antiproliferative
antiproliferative activity
antitumoral activity
antrodin C
apoptosis
AR
Artemisia absinthium
ASE
Aspergillus fumigatus
ATM-Chk2
autophagic flux inhibition
autophagy
bee venom
betulinic acid
Brazilian Cerrado biome
cancer
cancer stem cells
capsazepine
carrageenan
Catalpa speciosa
Celastraceae
cell cycle arrest
cell proliferation
cell signaling
cephalotaxine
cervical cancer
Cheiloclinium cognatum
chemotherapeutic adjuvant
chemotherapy
chiral resolution
CIP2A
CLE-10
CLEFMA
Colocasia esculenta
colorectal cancer cells
copper
Cordyceps sinensis
coronarin D
CrataBL
cryptolepine
Cucurbitacin B
cytotoxic activity
cytotoxicity
Dendrobium officinale
diallyl disulfide
dicentrine
DLD-1 cells
doxorubicin
drug resistance
ECD calculation
EGFR
endoplasmic reticulum stress
entrapment efficiency
Euphorbia tirucalli
FAK/S6K1
flavonoids
folk medicine
food bioactive
FOXO1
fruit
Ganoderma tsugae
gastric cancer
gastric cancer cells
gefitinib-resistant NSCLC
Gene expression
glioblastoma
glioblastoma multiforme
glioma
glucose uptake
glycosyltransferase
grape leaves
human neuroblastoma cells
IL-6/JAK2/STAT3
inflammation
inflammatory diseases
ingenol
invasion
isochromanes
isocryptolepine
JNK
lactoferrin hydrolysate
LC3
lichen
Licochalcone A
lipogenesis
lung adenocarcinoma
lysosomal degradation
lysosomal membrane permeabilization
Magnolia acuminata
manganese
MAPK
MCF-7 cells
MDA-MB-231
melanoma
melittin
mesenchymal stem cells
metabolic stability
metastasis
microenvironment
migration
mitochondrial membrane potential
mitochondrial ROS
mitochondrial-dependent pathway
molecular mechanism
mTOR
multiple myeloma
n/a
naringenin
natural compounds
natural product alkaloids
natural products
natural yellow Monascus pigments
NCI-60 cancer cell line
necrotic
neferine
neocryptolepine
NF-κB
no-toxicity
Nutraceuticals
oncogene
osteosarcoma
p38
patuletin
phenols
phloretin
phytochemicals
PI3K/AKT/mTOR
PI3K/Akt/mTOR pathway
plant lectin
plant-derived foods
plantation mode
Plenckia populnea
porphyran
preclinical tests
pristimerin
pro-apoptotic effects
proanthocyanins
prostate cancer
protease inhibitor
protein kinase C
protein synthesis inhibition
Pulsatilla saponin D
quality control
quercetagetin
quercetin
ROS
RT-R breast cancer cells
Salacia crassifolia
Salacia elliptica
SB365
seaweed
secondary metabolites
semi-synthetic derivative
SREBP-1
stable nanocapsules
stemness potential
structure activity relationships
structure elucidation
tarin
Taxus cuspidata
temozolomide
TNF-α
TP
traditional preparation
transcriptional regulation
triterpenoids
TRPV1
tumidulin
ursolic acid
vegetable
water-soluble
zerumbone
Zeylenone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557419703321
Fabiani Roberto  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Treatment Strategies for Glioblastoma
Novel Treatment Strategies for Glioblastoma
Autore Stylli Stanley
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (268 p.)
Soggetto topico Medicine
Soggetto non controllato angiopoietin (Ang)
anti-angiogenesis
anticancer
brain cancer
brain tumor
cancer stem cell
cancer stem cell niche
cancer stem cells
cell cycle
chimeric antigen receptor (CAR) T cells
CK2
CRISPR/Cas9
CX-4945
de novo purine synthesis
differentiation
drug repurposing
drug targets
drug-inducible gene expression
endothelial nitric oxide synthase (eNOS)
GBM
gene therapy
glioblastoma
glioblastoma (GB)
glioblastoma multiforme
glioma
immune checkpoint inhibitors
immunotherapy
invadopodia
invasion
ion channels
Mardepodect
metabolic reprogramming
metabolic treatment
migration
n/a
nanomedicine
nerve/glial antigen 2
new trial design
newly diagnosed glioblastoma
NG2
novel therapy
one-carbon metabolism
organoids
P-bi-TAT
P-m-TAT
PEG
personalized treatment
pluripotent stem cells
proliferation
prolyl-oligopeptidase (POP)
radiotherapy
RAS
recurrent glioblastoma
Regorafenib
renin-angiotensin system
SRGAP2
stem cell
targeted therapy
temozolomide
tetrac
thyrointegrin αvβ3
TP53
transforming growth factor-β (TGF-β)
triazole tetrac
tumor antigens
tumor microenvironment
vaccine
vascular endothelial growth factor (VEGF)
viral vectors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557363703321
Stylli Stanley  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of miRNAs in Cancer : Analysis of Their Targetome
Role of miRNAs in Cancer : Analysis of Their Targetome
Autore Navarro Alfons
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (302 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato adrenocortical carcinoma
angiogenesis
biomarker
Bladder cancer
breast cancer
Burkitt lymphoma
cancer
cancer diagnosis
cancer treatment
ccRCC
cell growth
chemotherapy
circular RNAs
drug resistance
EBV
EMT
EP4
epithelial to mesenchymal transition (EMT)
exosomes
genetic marker
glioblastoma
HBV
HCV
HHV-8
HPV
immune regulation
interplay
liquid biopsies
liquid biopsy
long non-coding RNAs (lncRNAs)
lymphangiogenesis
MCPyV
metastasis
MGMT
micro RNA
microRNA
microRNA-361
microRNAs
miR-378a-3p
miR526b
miR655
miRNA
n/a
non-coding RNA
oncomiRNA
pancreatic cancer
personalized medicine
PI3K/Akt
post-transcriptional regulation
prognosis
prognostic biomarker
progression
radioactive iodine
radioresistance
radiotherapy
SNAIL (SNAI1) transcription factor
survival
target
temozolomide
thyroid carcinoma
transcription factor
translational medicine
tumor
tumor microenvironment
viral miRNAs
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Role of miRNAs in Cancer
Record Nr. UNINA-9910566464803321
Navarro Alfons  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui